Management of Endometriosis

Treatment of endometriosis is broadly classified into pharmacological and surgical methods. Because the etiology of the disease is not well established, none of the currently available treatments can prevent or cure endometriosis. Rather, treatment is aimed mainly at providing symptom relief or improving fertility rates [1]. Therefore, one should consider how treatment options affect pain levels and infertility when investigating whether endometriosis treatment improves quality of life. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Platteeuw, L., & D’Hooghe, T. (2014). Novel agents for the medical treatment of endometriosis. Current Opinion in Obstetrics and Gynecology, 26(4), 243–252. Dunselman, G. A., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D’Hooghe, T., De Bie, B., et al. (2014). ESHRE guideline: Management of women with endometriosis. Human Reproduction (Oxford, England), 29(3), 400–412. Muzii, L., & Panici, P. B. (2010). Combined technique of excision and ablation for the surgical treatment of ovarian endometriomas: The way forward? Reproductive Biomedicine Online, 20(2), 300–302. Practice Committee of the American Society for Reproductive Medicine. (2006). Treatment of pelvic pain associated with endometriosis. Fertility and Sterility, 86(5 Suppl 1), S18–S27. Gambone, J. C., Mittman, B. S., Munro, M. G., Scialli, A. R., & Winkel, C. A. (2002). Consensus statement for the management of chronic pelvic pain and endometriosis: Proceedings of an expert-panel consensus process. Fertility and Sterility, 78(5), 961–972. Somigliana, E., Vigano, P., Barbara, G., & Vercellini, P. (2009). Treatment of endometriosis-related pain: Options and outcomes. Frontiers in Bioscience (Elite Edition), 1, 455–465. Vercellini, P., Somigliana, E., Vigano, P., Abbiati, A., Daguati, R., & Crosignani, P. G. (2008). Endometriosis: Current and future medical therapies. Best Practice & Research. Clinical Obstetrics & Gynaecology, 22(2), 275–306. Sulak, P. J., Cressman, B. E., Waldrop, E., Holleman, S., & Kuehl, T. J. (1997). Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstetrics and Gynecology, 89(2), 179–183. Coffee, A. L., Sulak, P. J., & Kuehl, T. J. (2007). Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception, 75(6), 444–449. Harada, T., Momoeda, M., Taketani, Y., Hoshiai, H., & Terakawa, N. (2008). Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-controlled, double-blind, randomized trial. Fertility and Sterility, 90(5), 1583–1588. Olive, D. L. (2003). Medical therapy of endometriosis. Seminars in Reproductive Medicine, 21(2), 209–222. Schlaff, W. D., Carson, S. A., Luciano, A., Ross, D., & Bergqvist, A. (2006). Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertility and Sterility, 85(2), 314–325. Brown, J., Kives, S., & Akhtar, M. (2012). Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database of Systematic Reviews, 3, CD002122. Rocha, A. L., Reis, F. M., & Petraglia, F. (2012). New trends for the medical treatment of endometriosis. Expert Opinion on Investigational Drugs, 21(7), 905–919. Lockhat, F. B., Emembolu, J. O., & Konje, J. C. (2004). The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Human Reproduction (Oxford, England), 19(1), 179–184. Angioni, S., Cofelice, V., Pontis, A., Tinelli, R., & Socolov, R. (2014). New trends of progestins treatment of endometriosis. Gynecological Endocrinology, 30(11), 769–773. Petta, C. A., Ferriani, R. A., Abrao, M. S., Hassan, D., Rosa, E. S. J. C., Podgaec, S., et al. (2005). Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Human Reproduction (Oxford, England), 20(7), 1993–1998. Sagsveen, M., Farmer, J. E., Prentice, A., & Breeze, A. (2003). Gonadotrophin-releasing hormone analogues for endometriosis: Bone mineral density. The Cochrane Database of Systematic Reviews (4): CD001297. Crosignani, P. G., & Somigliana, E. (2007). Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: A multicentre randomized trial. Human Reproduction (Oxford, England), 22(2), 500–505. Selak, V., Farquhar, C., Prentice, A., & Singla, A. (2001). Danazol for pelvic pain associated with endometriosis. The Cochrane Database of Systematic Reviews (4): CD000068. Telimaa, S., Puolakka, J., Ronnberg, L., & Kauppila, A. (1987). Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecological Endocrinology, 1(1), 13–23. Rotondi, M., Labriola, D., Rotondi, M., Ammaturo, F. P., Amato, G., Carella, C., et al. (2002). Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. European Journal of Gynaecological Oncology, 23(6), 523–526. Velasco, I., Rueda, J., & Acien, P. (2006). Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Molecular Human Reproduction, 12(6), 377–381. Pavone, M. E., & Bulun, S. E. (2012). Aromatase inhibitors for the treatment of endometriosis. Fertility and Sterility, 98(6), 1370–1379. Abu Hashim, H. (2014). Potential role of aromatase inhibitors in the treatment of endometriosis. International Journal of Women’s Health, 6, 671–680. Amsterdam, L. L., Gentry, W., Jobanputra, S., Wolf, M., Rubin, S. D., & Bulun, S. E. (2005). Anastrazole and oral contraceptives: A novel treatment for endometriosis. Fertility and Sterility, 84(2), 300–304. Ailawadi, R. K., Jobanputra, S., Kataria, M., Gurates, B., & Bulun, S. E. (2004). Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: A pilot study. Fertility and Sterility, 81(2), 290–296. Remorgida, V., Abbamonte, H. L., Ragni, N., Fulcheri, E., & Ferrero, S. (2007). Letrozole and norethisterone acetate in rectovaginal endometriosis. Fertility and Sterility, 88(3), 724–726. Hamann, G. O. (1980). Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation. Prostaglandins, 19(5), 651–657. Hanson, F. W., Izu, A., & Henzl, M. R. (1978). Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities. Obstetrics and Gynecology, 52(5), 583–587. Zito, G., Luppi, S., & Giolo, E. (2014). Medical treatments for endometriosis-associated pelvic pain. BioMed Research International, 2014, 191967. Allen, C., Hopewell, S., Prentice, A., & Gregory, D. (2009). Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database of Systematic Reviews, 2, CD004753. Pandi-Perumal, S. R., Trakht, I., Srinivasan, V., Spence, D. W., Maestroni, G. J., Zisapel, N., et al. (2008). Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways. Progress in Neurobiology, 85(3), 335–353. Guney, M., Oral, B., Karahan, N., & Mungan, T. (2008). Regression of endometrial explants in a rat model of endometriosis treated with melatonin. Fertility and Sterility, 89(4), 934–942. Koc, O., Gunduz, B., Topcuoglu, A., Bugdayci, G., Yilmaz, F., & Duran, B. (2010). Effects of pinealectomy and melatonin supplementation on endometrial explants in a rat model. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 153(1), 72–76. Schwertner, A., Conceicao Dos Santos, C. C., Costa, G. D., Deitos, A., de Souza, A., de Souza, I. C., et al. (2013). Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial. Pain, 154(6), 874–881. Johnson, N. P., & Hummelshoj, L. (2013). Consensus on current management of endometriosis. Human Reproduction (Oxford, England), 28(6), 1552–1568. Jin, X., & Ruiz Beguerie, J. (2014). Laparoscopic surgery for subfertility related to endometriosis: A meta-analysis. Taiwanese Journal of Obstetrics & Gynecology, 53(3), 303–308. Mais, V., Ajossa, S., Guerriero, S., Mascia, M., Solla, E., & Melis, G. B. (1996). Laparoscopic versus abdominal myomectomy: A prospective, randomized trial to evaluate benefits in early outcome. American Journal of Obstetrics and Gynecology, 174(2), 654–658. Luciano, A. A., Lowney, J., & Jacobs, S. L. (1992). Endoscopic treatment of endometriosis-associated infertility. Therapeutic, economic and social benefits. The Journal of Reproductive Medicine, 37(7), 573–576. Duffy, J. M., Arambage, K., Correa, F. J., Olive, D., Farquhar, C., Garry, R., et al. (2014). Laparoscopic surgery for endometriosis. The Cochrane Database of Systematic Reviews, 4: CD011031. Hart, R. J., Hickey, M., Maouris, P., & Buckett, W. (2008). Excisional surgery versus ablative surgery for ovarian endometriomata. The Cochrane Database of Systematic Reviews (2): CD004992. Roman, J. D. (2010). Surgical treatment of endometriosis in private practice: Cohort study with mean follow-up of 3 years. Journal of Minimally Invasive Gynecology, 17(1), 42–46. Biacchiardi, C. P., Piane, L. D., Camanni, M., Deltetto, F., Delpiano, E. M., Marchino, G. L., et al. (2011). Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reproductive Biomedicine Online, 23(6), 740–746. Benschop, L., Farquhar, C., van der Poel, N., & Heineman, M. J. (2010). Interventions for women with endometrioma prior to assisted reproductive technology. The Cochrane Database of Systematic Reviews (11): CD008571. Aflatoonian, A., Rahmani, E., & Rahsepar, M. (2013). Assessing the efficacy of aspiration and ethanol injection in recurrent endometrioma before IVF cycle: A randomized clinical trial. Iranian Journal of Reproductive Medicine, 11(3), 179–184. Pabuccu, R., Onalan, G., Goktolga, U., Kucuk, T., Orhon, E., & Ceyhan, T. (2004). Aspiration of ovarian endometriomas before intracytoplasmic sperm injection. Fertility and Sterility, 82(3), 705–711. Kars, B., Buyukbayrak, E. E., Karsidag, A. Y., Pirimoglu, M., Unal, O., & Turan, C. (2012). Comparison of success rates of ‘transvaginal aspiration and tetracycline sclerotherapy’ versus ‘only aspiration’ in the management of non-neoplastic ovarian cysts. The Journal of Obstetrics and Gynaecology Research, 38(1), 65–69. Afors, K., Murtada, R., Centini, G., Fernandes, R., Meza, C., Castellano, J., et al. (2014). Employing laparoscopic surgery for endometriosis. Women’s Health (London, England), 10(4), 431–443. Barnhart, K., Dunsmoor-Su, R., & Coutifaris, C. (2002). Effect of endometriosis on in vitro fertilization. Fertility and Sterility, 77(6), 1148–1155. Marcoux, S., Maheux, R., & Berube, S. (1997). Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. The New England Journal of Medicine, 337(4), 217–222. Kodama, H., Fukuda, J., Karube, H., Matsui, T., Shimizu, Y., & Tanaka, T. (1996). Benefit of in vitro fertilization treatment for endometriosis-associated infertility. Fertility and Sterility, 66(6), 974–979. Opoien, H. K., Fedorcsak, P., Omland, A. K., Abyholm, T., Bjercke, S., Ertzeid, G., et al. (2012). In vitro fertilization is a successful treatment in endometriosis-associated infertility. Fertility and Sterility, 97(4), 912–918. de Ziegler, D., Borghese, B., & Chapron, C. (2010). Endometriosis and infertility: Pathophysiology and management. Lancet, 376(9742), 730–738. Chuang, P. C., Wu, M. H., Shoji, Y., & Tsai, S. J. (2009). Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. The Journal of Pathology, 219(2), 232–241. Tsoumpou, I., Kyrgiou, M., Gelbaya, T. A., & Nardo, L. G. (2009). The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: A systematic review and meta-analysis. Fertility and Sterility, 92(1), 75–87. Suzuki, T., Izumi, S., Matsubayashi, H., Awaji, H., Yoshikata, K., & Makino, T. (2005). Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Fertility and Sterility, 83(4), 908–913. Padilla, S. L. (1993). Ovarian abscess following puncture of an endometrioma during ultrasound-guided oocyte retrieval. Human Reproduction (Oxford, England), 8(8), 1282–1283. Yaron, Y., Peyser, M. R., Samuel, D., Amit, A., & Lessing, J. B. (1994). Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Human Reproduction (Oxford, England), 9(9), 1759–1760. Shimizu, Y., Takashima, A., Takahashi, K., Kita, N., Fujiwara, M., & Murakami, T. (2010). Long-term outcome, including pregnancy rate, recurrence rate and ovarian reserve, after laparoscopic laser ablation surgery in infertile women with endometrioma. The Journal of Obstetrics and Gynaecology Research, 36(1), 115–118. Donnez, J., Wyns, C., & Nisolle, M. (2001). Does ovarian surgery for endometriomas impair the ovarian response to gonadotropin? Fertility and Sterility, 76(4), 662–665. Marconi, G., Vilela, M., Quintana, R., & Sueldo, C. (2002). Laparoscopic ovarian cystectomy of endometriomas does not affect the ovarian response to gonadotropin stimulation. Fertility and Sterility, 78(4), 876–878. Donnez, J., Pirard, C., Smets, M., Jadoul, P., & Squifflet, J. (2004). Surgical management of endometriosis. Best Practice & Research. Clinical Obstetrics & Gynaecology, 18(2), 329–348. Garcia-Velasco, J. A., Mahutte, N. G., Corona, J., Zuniga, V., Giles, J., Arici, A., et al. (2004). Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: A matched, case-control study. Fertility and Sterility, 81(5), 1194–1197. Canis, M., Pouly, J. L., Tamburro, S., Mage, G., Wattiez, A., & Bruhat, M. A. (2001). Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of >3 cm in diameter. Human Reproduction (Oxford, England), 16(12), 2583–2586. Kahyaoglu, S., Ertas, E., Kahyaoglu, I., Mollamahmutoglu, L., & Batioglu, S. (2008). Does laparoscopic cystectomy and cauterization of endometriomas greater than 3 cm diminish ovarian response to controlled ovarian hyperstimulation during IVF-ET? A case-control study. The Journal of Obstetrics and Gynaecology Research, 34(6), 1010–1013. Tsolakidis, D., Pados, G., Vavilis, D., Athanatos, D., Tsalikis, T., Giannakou, A., et al. (2010). The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: A prospective randomized study. Fertility and Sterility, 94(1), 71–77. Donnez, J., Lousse, J. C., Jadoul, P., Donnez, O., & Squifflet, J. (2010). Laparoscopic management of endometriomas using a combined technique of excisional (cystectomy) and ablative surgery. Fertility and Sterility, 94(1), 28–32. Garcia-Velasco, J. A., & Somigliana, E. (2009). Management of endometriomas in women requiring IVF: To touch or not to touch. Human Reproduction (Oxford, England), 24(3), 496–501. Senapati, S., & Barnhart, K. (2011). Managing endometriosis-associated infertility. Clinical Obstetrics and Gynecology, 54(4), 720–726. Psaroudakis, D., Hirsch, M., & Davis, C. (2014). Review of the management of ovarian endometriosis: Paradigm shift towards conservative approaches. Current Opinion in Obstetrics and Gynecology, 26(4), 266–274. Kulak, J., Jr., Fischer, C., Komm, B., & Taylor, H. S. (2011). Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model. Endocrinology, 152(8), 3226–3232. Lessey, B. A., Metzger, D. A., Haney, A. F., & McCarty, K. S., Jr. (1989). Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: Comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertility and Sterility, 51(3), 409–415. Wolf, J. P., Hsiu, J. G., Anderson, T. L., Ulmann, A., Baulieu, E. E., & Hodgen, G. D. (1989). Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertility and Sterility, 52(6), 1055–1060. Chwalisz, K., Perez, M. C., Demanno, D., Winkel, C., Schubert, G., & Elger, W. (2005). Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocrine Reviews, 26(3), 423–438. Siristatidis, C., Nissotakis, C., Chrelias, C., Iacovidou, H., & Salamalekis, E. (2006). Immunological factors and their role in the genesis and development of endometriosis. The Journal of Obstetrics and Gynaecology Research, 32(2), 162–170. D’Antonio, M., Martelli, F., Peano, S., Papoian, R., & Borrelli, F. (2000). Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats. Journal of Reproductive Immunology, 48(2), 81–98. D’Hooghe, T. M., Nugent, N. P., Cuneo, S., Chai, D. C., Deer, F., Debrock, S., et al. (2006). Recombinant human TNFRSF1A (r-hTBP1) inhibits the development of endometriosis in baboons: A prospective, randomized, placebo- and drug-controlled study. Biology of Reproduction, 74(1), 131–136. Falconer, H., Mwenda, J. M., Chai, D. C., Wagner, C., Song, X. Y., Mihalyi, A., et al. (2006). Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Human Reproduction (Oxford, England), 21(7), 1856–1862. Chen, Y. J., Wu, H. H., Liau, W. T., Tsai, C. Y., Tsai, H. W., Chao, K. C., et al. (2013). A tumor necrosis factor-alpha inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid. Fertility and Sterility, 100(5), 1476–1485. Lu, D., Song, H., & Shi, G. (2013). Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. The Cochrane Database of Systematic Reviews, 3: CD008088. Piotrowski, P. C., Kwintkiewicz, J., Rzepczynska, I. J., Seval, Y., Cakmak, H., Arici, A., et al. (2006). Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. Biology of Reproduction, 75(1), 107–111. Oktem, M., Esinler, I., Eroglu, D., Haberal, N., Bayraktar, N., & Zeyneloglu, H. B. (2007). High-dose atorvastatin causes regression of endometriotic implants: A rat model. Human Reproduction (Oxford, England), 22(5), 1474–1480. Yilmaz, B., Ozat, M., Kilic, S., Gungor, T., Aksoy, Y., Lordlar, N., et al. (2010). Atorvastatin causes regression of endometriotic implants in a rat model. Reproductive Biomedicine Online, 20(2), 291–299. Cakmak, H., Basar, M., Seval-Celik, Y., Osteen, K. G., Duleba, A. J., Taylor, H. S., et al. (2012). Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reproductive Sciences, 19(6), 572–579. Oner, G., Ozcelik, B., Ozgun, M. T., Serin, I. S., Ozturk, F., & Basbug, M. (2010). The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. Human Reproduction (Oxford, England), 25(4), 932–937. Yilmaz, B., Sucak, A., Kilic, S., Aksakal, O., Aksoy, Y., Lortlar, N., et al. (2010). Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. American Journal of Obstetrics and Gynecology, 202(4): 368.e361–e368. Novella-Maestre, E., Carda, C., Noguera, I., Ruiz-Sauri, A., Garcia-Velasco, J. A., Simon, C., et al. (2009). Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Human Reproduction (Oxford, England), 24(5), 1025–1035. Ercan, C. M., Kayaalp, O., Cengiz, M., Keskin, U., Yumusak, N., Aydogan, U., et al. (2015). Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model. Archives of Gynecology and Obstetrics, 291(5), 1103–1111. Serafini, M., Del Rio, D., Yao, D. N., Bettuzzi, S., & Peluso, I. (2011). Health benefits of tea. In I. F. F. Benzie & S. Wachtel-Galor (Eds.), Herbal medicine: Biomolecular and clinical aspects. Boca Raton, FL: CRC Press/Llc. Laschke, M. W., Schwender, C., Scheuer, C., Vollmar, B., & Menger, M. D. (2008). Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Human Reproduction (Oxford, England), 23(10), 2308–2318. Xu, H., Lui, W. T., Chu, C. Y., Ng, P. S., Wang, C. C., & Rogers, M. S. (2009). Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Human Reproduction (Oxford, England), 24(3), 608–618. da Silva, C. M., Vilaca Belo, A., Passos Andrade, S., Peixoto Campos, P., Cristina Franca Ferreira, M., Lopes da Silva-Filho, A., et al. (2014). Identification of local angiogenic and inflammatory markers in the menstrual blood of women with endometriosis. Biomedicine and Pharmacotherapy, 68(7), 899–904. Tokushige, N., Markham, R., Russell, P., & Fraser, I. S. (2006). Nerve fibres in peritoneal endometriosis. Human Reproduction (Oxford, England), 21(11), 3001–3007. Wickstrom, K., Bruse, C., Sjosten, A., Spira, J., & Edelstam, G. (2013). Quality of life in patients with endometriosis and the effect of pertubation with lidocaine—A randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica, 92(12), 1375–1382. Edelstam, G., Sjosten, A., Jablonowska, B., Kjellberg, S., & Spira, J. (2012). Pertubation with lidocaine—A non-hormonal, long-term treatment of dysmenorrhea due to endometriosis. Sexual & Reproductive Healthcare, 3(2), 93–94. Nezhat, C. R., Stevens, A., Balassiano, E., & Soliemannjad, R. (2015). Robotic-assisted laparoscopy vs conventional laparoscopy for the treatment of advanced stage endometriosis. Journal of Minimally Invasive Gynecology, 22(1), 40–44. Sirota, I., & Nezhat, F. (2014). Robotic compared with conventional laparoscopy for treatment of severe endometriosis: Comparison of outcomes. Obstetrics and Gynecology, 123(Suppl 1), 129s–130s. Hwang, J. H., Lee, K. S., Joo, J. K., Wang, T., Son, J. B., Park, J. H., et al. (2014). Identification of biomarkers for endometriosis in plasma from patients with endometriosis using a proteomics approach. Molecular Medicine Reports, 10(2), 725–730. May, K. E., Conduit-Hulbert, S. A., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2010). Peripheral biomarkers of endometriosis: A systematic review. Human Reproduction Update, 16(6), 651–674. Deane, J. A., Gualano, R. C., & Gargett, C. E. (2013). Regenerating endometrium from stem/progenitor cells: Is it abnormal in endometriosis, Asherman’s syndrome and infertility? Current Opinion in Obstetrics and Gynecology, 25(3), 193–200. Chan, R. W., Ng, E. H., & Yeung, W. S. (2011). Identification of cells with colony-forming activity, self-renewal capacity, and multipotency in ovarian endometriosis. The American Journal of Pathology, 178(6), 2832–2844. Trent, R. J., & Alexander, I. E. (2004). Gene therapy: Applications and progress towards the clinic. Internal Medicine Journal, 34(11), 621–625. Dabrosin, C., Gyorffy, S., Margetts, P., Ross, C., & Gauldie, J. (2002). Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. The American Journal of Pathology, 161(3), 909–918. Othman, E. E., Zhu, Z. B., Curiel, D. T., Khatoon, N., Salem, H. T., Khalifa, E. A., et al. (2008). Toward gene therapy of endometriosis: Transductional and transcriptional targeting of adenoviral vectors to endometriosis cells. American Journal of Obstetrics and Gynecology, 199(2): 117.e111–e116. Hassan, M. H., Othman, E. E., Hornung, D., & Al-Hendy, A. (2009). Gene therapy of benign gynecological diseases. Advanced Drug Delivery Reviews, 61(10), 822–835. Author information Authors and Affiliations Corresponding author Rights and permissions Copyright information © 2015 The Author(s) About this chapter Cite this chapter Gupta, S., Harlev, A., Agarwal, A., Rakhit, M., Ellis-Kahana, J., Parikh, S. (2015). Management of Endometriosis. In: Endometriosis. SpringerBriefs in Reproductive Biology. Springer, Cham. https://doi.org/10.1007/978-3-319-18308-4_10 Download citation DOI: https://doi.org/10.1007/978-3-319-18308-4_10 Publisher Name: Springer, Cham Print ISBN: 978-3-319-18307-7 Online ISBN: 978-3-319-18308-4 eBook Packages: MedicineMedicine (R0)

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.